PATENT CLAIM ANALYSIS

Application Number: 16037150
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "007320"]

Abstract:
The present invention concerns a composition comprising at least three peptides derived from  Mycobacterium tuberculosis  antigen Rv2626c, its use in the diagnostic of latently infected  Mycobacterium tuberculosis  (LTBI) subjects, corresponding methods of use and kits.

Claim (Index 4):
A composition according to  claim 1  in which said at least three peptides are chosen from:\n peptide 6 of SEQ ID No 2 or a fragment of at least 3 amino acids thereof; \n peptide 12 of SEQ ID No 3 or a fragment of at least 3 amino acids thereof; \n peptide 18 of SEQ ID No 4 or a fragment of at least 3 amino acids thereof; \n peptide 24 of SEQ ID No 5 or a fragment of at least 3 amino acids thereof; \n peptide 30 of SEQ ID No 6 or a fragment of at least 3 amino acids thereof; \n peptide 36 of SEQ ID No 7 or a fragment of at least 3 amino acids thereof; \n peptide 7 of SEQ ID No 8 or a fragment of at least 3 amino acids thereof; \n peptide 8 of SEQ ID No 9 or a fragment of at least 3 amino acids thereof; \n peptide 9 of SEQ ID No 10 or a fragment of at least 3 amino acids thereof; \n peptide 10 of SEQ ID No 11 or a fragment of at least 3 amino acids thereof; \n peptide 11 of SEQ ID No 12 or a fragment of at least 3 amino acids thereof; \n peptide 19 of SEQ ID No 13 or a fragment of at least 3 amino acids thereof; \n peptide 20 of SEQ ID No 14 or a fragment of at least 3 amino acids thereof; \n peptide 21 of SEQ ID No 15 or a fragment of at least 3 amino acids thereof; \n peptide 22 of SEQ ID No 16 or a fragment of at least 3 amino acids thereof; \n peptide 23 of SEQ ID No 17 or a fragment of at least 3 amino acids thereof; \n peptide 31 of SEQ ID No 18 or a fragment of at least 3 amino acids thereof; \n peptide 32 of SEQ ID No 19 or a fragment of at least 3 amino acids thereof; \n peptide 33 of SEQ ID No 20 or a fragment of at least 3 amino acids thereof; \n peptide 34 of SEQ ID No 21 or a fragment of at least 3 amino acids thereof; \n peptide 35 of SEQ ID No 22 or a fragment of at least 3 amino acids thereof; \n peptide 1 of SEQ ID No 25 or a fragment of at least 3 amino acids thereof; \n peptide 2 of SEQ ID No 26 or a fragment of at least 3 amino acids thereof; \n peptide 3 of SEQ ID No 27 or a fragment of at least 3 amino acids thereof; \n peptide 4 of SEQ ID No 28 or a fragment of at least 3 amino acids thereof; \n peptide 5 of SEQ ID No 29 or a fragment of at least 3 amino acids thereof; \n peptide 13 of SEQ ID No 30 or a fragment of at least 3 amino acids thereof; \n peptide 14 of SEQ ID No 31 or a fragment of at least 3 amino acids thereof; \n peptide 15 of SEQ ID No 32 or a fragment of at least 3 amino acids thereof; \n peptide 16 of SEQ ID No 33 or a fragment of at least 3 amino acids thereof; \n peptide 17 of SEQ ID No 34 or a fragment of at least 3 amino acids thereof; \n peptide 25 of SEQ ID No 35 or a fragment of at least 3 amino acids thereof; \n peptide 26 of SEQ ID No 36 or a fragment of at least 3 amino acids thereof; \n peptide 27 of SEQ ID No 37 or a fragment of at least 3 amino acids thereof; \n peptide 28 of SEQ ID No 38 or a fragment of at least 3 amino acids thereof; and \n peptide 29 of SEQ ID No 39 or a fragment of at least 3 amino acids thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.14286
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15505292', '13263442', '15104957', '13119938', '10593384']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6217916021540921
- 35 USC 102 Novelty (BERT): 0.568862188301375
- Combined Prediction Score: 0.6164986607688205
- Mean Citation Score: 364.22367
- Max Citation Score: 527.5229
- Similarity Product: 315.2464813587308

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test